Do Markets and the Division of Labour Encourage or Discourage Social Essay

Do Markets and the Division of Labour Encourage or Discourage Social Cohesion - Essay Example Specialization is when tasks in a society are assigned to specific individuals in whereby the assigned person has the obligation of fully completing the task. Markets on the other hand are defined as the a place where economic activities in the society take place, economic activities in this case imply to the buying and selling and thus there is interaction and the interaction of buyers and sellers from different cultures and ethnical backgrounds. Markets and division of labor’s contribution towards social cohesion has been a crucial debatable issue in the contemporary practical environment (Council of Europe 2006). Markets and division of labor according to the definition of Adam Smith can be used to explain the reason why on the adoption of this technique there is increased productivity and output in regards to the economic activities of a given society. The major objective and aim of markets and division of labor is to ensure that there is consistent maximization of profits as well as minimizing the average total cost of the production process. There are several classes of thinkers on this issue of social cohesion in regards to markets and the division of labor. This argument has been highly attributed by the several definitions of markets and division of labor in the contemporary society. ... The other class of thought based their definition of labor on the principles of the social and collective human labor. The principle behind this definition is that markets and division of labor collectively pulled together the society thus encouraging the collective achievement of social and cultural interaction and integration and intellectualism in the society. Basing on these definitions the perception of markets and division of labor on promoting social cohesion is positive. Other scholars on the basis that the concerned definition has not fully integrated the concept of the political economy have opposed this justification. The definition of markets and division of labour has since been not compatible with the current political, social and economic setup of the society. This has been due to the over emphasis of the social cohesion in the original definition, social cohesion in the context of markets and division of labour can be evaluated in critically looking at the merits and the demerits on the societal integration and cohesion (Rogowski 2008). Division of labor in the past was seen as the source of labour discrimination in the society, this was attributed by the presence of gender imbalance, inequalities and variation in the various in the sectors in the production process (O'Brien 2008).According to Angle, division of labour was in existence in as far as the human history is concerned. He believes that the division of labour is one of the major sources of the intrigues being witnessed in the society. Challenges such as human beings being denied rights as well as unfavorable social set up emerged due to the division of labour thus this scholar implies that markets and division of labour have contributed

Plato, Aristotle, Sophism Essay Example | Topics and Well Written Essays - 500 words

Plato, Aristotle, Sophism - Essay Example Plato’s point is that the prisoners would be highly mistaken in that they would be taking terms in their own language to refer to the shadow that comes before their eyes rather than to the real things that bring the shadows. In this manner, Plato meant that the general terms of human language are not names of the physical objects or things that we can see. They are names of objects or things that we are not able to see, objects or things we can only comprehend with our mind. Plato’s aim in the republic is to explain what is important for us to attain this reflective understanding of real world. It remains the fact that our very ability to think and speak depends upon the forms. The terms of the language that people use, we get their real or true meaning by naming the forms that the things we perceive engage in. In addition, Plato tried to illustrate human nature for education and our want for education. For Aristotle, a firm understanding of what a cause is, and how many types of causes there are, is significant for successful explanation of the world around us. Aristotle identifies four kinds of things that can be applied in answer to a why-question: a. The material cause, which Aristotle stated that in every change, something gets a new determination first before undergoing any form of change, which is in potency to a new determination, then after that thing has been acted upon, it gets a new actualization. b. Formal cause, which states that every individual thing is made up not only matter, but also form. Form is the rule of determination, which accounts for the individual thing being the kind of thing it is. On the other hand, matter is the rule of potentiality, with the ability to become other than it is. c. Efficient cause, which states that, in addition to the causes that are aspects of material things, form, and matter, Aristotle, says that there must be a source for any change or motion. This according to Aristotle might be

Mobile Phones Essay Example for Free

Mobile Phones Essay Mobile phones have had such a large impact in our modern twenty-first century societies, that they have become part and parcel of our daily lives. Nowadays, it has become the norm in our towns and villages to see people who are busy tapping on their cell phones. Mobile phones have changed the way people communicate. These devices are carried anywhere people go because they are light and easy to carry around, such that everyone is constantly in touch with others. This is very different from when home and work telephones were the only means of communication. Nowadays, people can call each other using their mobile phones wherever they are as long as there is reception, regardless of the country they are in. This can be life-saving when emergency calls are needed, while also very useful to communicate with work colleagues, family and friends. Furthermore, mobile phones have also given birth to text messages, which are found to be more convenient than phone calls, because they can be answered at the receiver’s convenience without being disturbed. Read more:Â  Essay on Use of Mobile Phones by Students Smart phones are the latest kind of mobile devices, which have been available for only a couple of years. These phones continue to enhance our communication, mainly by using the internet for third party services, such as chatting and social networking sites. Moreover, these phones can be used for a multitude of other things, such that they are able to have the function of a computer, a music player, a camera, a video camera, a gaming console and a diary, among other uses. Mobile phones have also been of a disadvantage to their users. People in modern societies are often found to be addicted to their cell phones. They check if they have any new message over and over again, even when they are out with their friends or when they are on a date. Firstly, this obsession shows lack of manners because mobile phones are given more importance than the person in front of them. Secondly, this lack of priorities can often be dangerous, for example while driving. The latest smart phones could be very expensive. Even though there are a variety of affordable cell phones and smart phones, some people, most often youths, spend hundreds of Euros every year to buy the latest smart phone, although having only a small improvement over the previous one. Generally, this is a result of persuasive and costly advertising made by giant manufacturers. Furthermore, this has also been a common subject for bullying in schools. Mobile phones have obviously made people’s work and personal life much easier. As long as these are used with caution and moderation, cell phones do not have any particular negative impact on people’s lifestyle and health.

The Position Of Tesco In The Grocery Industry

The Position Of Tesco In The Grocery Industry The humble beginning of this grocery company started in 1919, and the name Tesco appeared first at the top of a shop at Edgware in 1929. This company has been growing in size and complexities ever since. The company is today the Britains leading retailer and the 3rd largest retailer in the world.(Guardian 2010) Presently, Tesco has more than 4,300 grocers, which now operate in 14 countries: South Korea, Malaysia, Japan, China, Republic of Ireland, Czech Republic, Slovakia, Turkey and Poland, Thailand, Asia, India and US. They have over 2,329 stores overseas and are still growing. The company is good at buying and selling. The company invest in what matters to people, and that is the major thing that propels Tesco progress. This progress bestowed on The Present Chief Executive Terry Leahy who has contributed immensely to the growth of the company and that is why he has spent 13 years in the position he is still maintaining that. This is evidenced by the launch of the Loyalty Scheme club card and Tesco.com, internet home shopping service etc. The company passed through the global recession and yet grew stronger than it was by recording a 10% increase in profit to a mighty  £3.4 billion at April 2010. 1.1 Environmental Analysis of Tesco (PEST) The environmental analysis of Tesco will help one understand what is happening both at the inside and outside of Tesco, and to increase the probability that the organisational strategies will appropriately reflect Tescos environment. The strategy of Tesco should be directed at exploiting the environmental opportunities and to block environmental threats in a way that is consistent with the internal capabilities (Robson, 1997). Although Tesco is waxing stronger and was able to declare 10% increase in profit in spite of the recession, the analysis is still important as to determine what might affect it in the future. Environmental analysis of a company should be continuous and feed all aspects of planning. Political Factors Presently, there is no huge recognisable factor affecting Tesco. However, the winner of the fourth coming election is still unknown. Speculations have it that the Labour might loose out for the conservatives. The new government coming in might bring in a lot of unfavourable or favourable laws and policies for the UK grocery industry and other industries as well. Economic Factors The scourge of global recession that hit around 2008, this affected a lot of sectors globally. It could rather be said that Tesco withstood it by improving on there strategy, by changing there prices to suite every classes of individuals without compromising the quality. This is evidenced by 10% increment in profit they declared this year, making over 3.4 billion this year. The chairman as at last year that I am pleased to report that despite the extra ordinary economic environment we find ourselves in, Tesco has once again delivered a good set of results. This demonstrates that Tesco is coping with the down town. Despite the challenging conditions around the globe we have remained resilient and are growing as fast as any major international retailer. (Tesco 2009). After the declaration of the huge 2010 profit, Terry Leahy declared the retailer stronger than it was before the recession. (Guardian 2010).Tesco used its strategy to beat the economic recession. So the economy had no nega tive e effect on Tesco. The spending power of people could equally affect groceries. The economic crunch has made quite a number of people change the way and manner at which they buy things. For instance, because of this economic crisis, a lot of people prefer to buy ingredient and cook because they see it cheaper to do so. Inflation is another powerful factor that could affect the grocery market. This is an incessant increase in the price of items and services, leading to a drop in the currencies purchasing power. Ta However, Economists believe that supply of money is the key factor of inflation.(Economy Watch 2010). Socio-cultural Factor Lifestyle, healthy and fresh produce, immigrants and produce lines.The behaviour of humans also matters in this business. Most customers prefer buying the Tesco branded products. They prefer they go for the fresh products. Tesco are sensitive to read people and know what they need with the club cards. The peoples religion might affect the way they buy things, they might declare fasting within a location it could be mostly in there international locations, and it will reduce the number of sales within such periods. So Tesco take time to consider these as it affects the business. The population of inhabitants and the kind of life they live and the class of people within an area affects a business. Technological Factor Technology is another key thing that contributes to Tescos success is the introduction of Tesco club card. This has helped Tesco in reading and knowing the need of over 16 million of there club card holders in the UK and over 400 million globally. They know what you need and they provide them, which is one of there key success factors. The implementation of Information technology has contributed towards the efficient management of inventories logistics and ware housing which helps in bringing the cost down. Automatic tills, their online operations, electronic supply chain management etc Industry Analysis UK grocery industry is a highly contributor towards UK economy, as buyers are in need everyday and people must satisfy their needs everyday. The buyers in the UK are equally very big because grocery/retail industry is a must in our everyday lives. There are a number of grocers in the UK: Tesco, Morrison, Asda, wal-mart, Sainsburys, Co-op, Iceland, Waitrose, MS, Netto, Farmfoods, Aldi, and Somerfield etc There are the major player in the industry which include Tesco , Sainsbury, Morrison, Iceland, Asda Wal-Mart, MS. The Grocery industry could be examined properly by adopting the Michael porters five forces. Which include the bargaining power of suppliers, the bargaining power of buyers, and threat of new entrants, Threats of substitutes and Rivalry among competitors? 2.1 Porter Five Forces: Tesco The bargaining power of supplier in this industry matters, the key player in the industry now is Tesco and there are others like Sainsburys, Iceland, Morrisons but Tesco is just the giant, in the UK grocery industry. They made a profit of  £3.4 billion this year 2010 despite the scourge of the economic down turn. Tesco as a competitor buy in a very large scale because they have over 2000 stores in the UK and about 2300 stores across the UK. They have a wider market share, and they have a very high advantage over there suppliers. This is critical success factor that Tesco picks on to keep on dominating in the industry. They could even fix prices for their suppliers. What then could be the fate of other competitors in the system? MS is great going by that brand name the company has. It is a nice advantage. Asda Wal-Mart is equally waxing well in the industry after it was acquired by Wal-Mart in 1999.They get there supplies within and outside of UK. Sainsburys adopted other means to beat the market, they grow there own organic products even their meat in order to grow and maintain stands in the market. They do this in collaboration with the farmers. The same applies to Morrisons and Iceland. They use other measures to get supplies, and they do not depend on a particular source of supplies. (Guardian 2010) Bargaining power of buyers in this industry is not so significant yet it matters in the sense that even though prices are fixed and the consumers (buyer) can not bargain, they can check in other outlets. In that case they will not buy the product. The availability of various grocers at a place will make prices drop more. Though the price drop down may not be in the favour of the competitors. It is beneficial to consumers, and not the buyers. For instance, Tesco as a top grocer, with over 2000 locations in UK and still expanding, have a higher market share, they have a higher supply advantage ,consumers will not have bargaining power over them, as they have already brought down their prices and have numerous locations scattered all over the city. This is most likely to be affecting other key players in the industry. New Entrant coming into the industry will easily start because of the large market share of the grocery industry but will rather find it very difficult to penetrate the market and beat the already existing competitors especially the giant like Tesco. The grocery environment in the UK could be seen as oligopolistic one. The major grocers in the UK are few and the market share for this industry is large. Yet it would be difficult for a new firm to spring up or rather the younger firms to rise, except for a bigger firm to acquire an existing one. Just like Wal-Mart acquired Asda in 1999. ( ASDA 2010). It is because of the high rate of competition in the industry, and most other grocers like Sainsburys, Morrisons, Iceland, and MS were adopted growth strategies, and where increasing there location most especially Tescos. The Grocers in the industry has diversified and they do a umber of different product ranging from home use products, electronics, technologies, automobile, etc. This is a strategy for them to survive in the industry. In this industry, threat of substitute does not really take so much effect; this is mostly all about food. Buying a product here is almost the same in the other shop. For instance buying a digestive biscuit in Tesco, you go to another shop to buy digestive of different brand, it does not make much effect because they are all biscuits. They do not deal on one item; they deal on a variety of items. So, one can not substitute tens of thousands of item, when a normal grocer does ten brand of same item or product. However, where threat could be envisaged is at, may be the health/hygiene product. For example, the government has publicized to encourage healthy eating. It recommends eating 5 a day it has been noted by many other food retailers, who now label their foods with in depth nutritional information. The degree of rivalry in the grocery industry in the UK is very high. Highly perishable items are part of the contributor of the rivalry in the industry. Tesco is indeed an extremely powerful economic force in the in the industry. They are growing every now and then. They have the highest number of branches in the UK; UK is their biggest market when compared to other locations outside the UK. This is evidenced by the huge profit of  £3.4 billion profit they recorded this 2010. It is a 10% increment in profit when compared to last years profit. It is today beloved that in every  £10 spent on grocery in the UK, Tescos account for  £3. Tesco occupy about 2/3 of the grocery market in the UK. Presently they are rated the 3rd retailer in the world. In addition to the degree of rivalry, this report will explain the competitors analysis that has been taken place in this industry (Quick MBA 2007). (remember to affix in text reference in the industry analysis where necessary) 3.0 Competitor Analysis for Tesco Porters five forces will be a better tool for accessing the stand point of Tesco in the grocery industry. These include the bargaining power of suppliers, the bargaining power of buyers, the threat of new entrant, threat of substitute and the degree of rivalry. The bargaining power of suppliers towards Tesco is very low, as Tesco is such a very large grocer. They have over 2000 stores within the UK only and 4300 stores in general, so as such they buy in a larger quantity far greater than its competitor. Going by this bulky purchase, the suppliers seem to be at their mercy because of their high demand of products. They tell the suppliers what to sell and they stick to that. Considering the huge profit they declared this year 2010, inspite of the economic downturn, the strategy they adopted was that they have envisaged the change in the behaviour of people, and they changed strategy by doing more discount, price ranging for various classes of people, whilst maintaining its quality, and doing more promotions. They tell the supplier what they will buy; they have no choice than to succumb to it. More so Tesco produce most of their foods and meat by employing or hiring people. (Tesco 2010). The bargaining power of buyers towards Tesco is obviously very poor. This report suggests that there is no power Tesco buyers have at all. Tesco is absolutely in charge. Tesco wields so much power in the grocery business and they have brought their prices so low to match different classes of people in the society. More over their prices are fixed already. They provide promo for their customers and issue free club cards that grants you point in any item you purchase that is above a pound. At the end they use it to calculate the points and read what your likes and shopping behaviour. With this, they give offers to its customers. So, Tesco always have their focus on its customers. (Guardian 2010). Threat of new entrant is never an issue to Tesco PLC because of their strengths, which include but are not limited to their brand name, the large number of their locations, The higher number of their staff, their chain business, The high power they have over their suppliers and buyer and so on. However, a new entrant can come as an existing world class retailer to acquire or merge with another top retailer that is the only way they could penetrate. Though even at that, it is still very difficult to beat Tesco most especially in the UK as it is evidenced in the 2010 Tescos strategic intent;to develop retailing services, maintain strong core UK business and be as strong as non-food, as in food. (Tesco 2010) Threat of new substitute could not be seen much in a high degree when it comes to Tesco and grocery industry at large. Tesco sell their branded food as well as other products from various brand. So any substitute that is food, every tendency is their for Tesco to sell it. Another thing is that because of their high bargaining power, they could buy over a producer and that product will be done in the name of Tesco. Nevertheless, the switching cost for customers could be easy, but it could be hindered by proximity barrier because before he could walk for 5 to 10 minutes, he will see another Tesco shop instead of others. One can not because of one item and travel so far. Tesco has withstood the threats of Rivalry in the grocery industry through a number of ways, these include: The long years of consistence and care towards its customers, Their high bargaining power, The loyalty they have built vis-à  -vis their customers, Their high network of branches, their technologies, chains of other businesses, high performance all year round, they where able to make huge profits this year 2010. 10% increment against what they made last year in spite of the global down turn.(Tesco 2010). It is also believed presently that out of every  £10 spent on food here in the UK, Tesco accounts for  £3 pounds Guardian 2010). More so, Tesco keeps on bringing in more and more strategies that will make them be the no.1 in the world as they hope to be as strong in non food as in food, an international retailer, Maintain a strong core UK business, develop retailing services and put community at the heart of what they do. The competition is there, but Tesco has a core competency in the grocery industry. They wield much power. (Tesco is in the star position of the BCG Matrix. They have a high market growth rate and a high market share. Their 2010 revenue is  £62.54 billion while the 2010 operational income is  £3.41 billion i.e. 10% increment against 2009). 4.0 Portfolio Analysis This could be seen as the collection of a business and product that make up the company. The best business portfolio is the one that match the companys strengths and help bring out the attractive opportunities. The two better best known portfolio planning methods are the BCG matrix and the McKinsey / General Electric Matrix. In GE Matrix, market attractiveness replaced market growth of BCG as the dimension of the industry attractiveness and includes other range of factors other than the Market growth rate. Secondly, competitive strength replaces market share as the dimension by which the competitive position of each SBU is assessed. (Tutor2u 2010) Market Growth Rate of Tesco Tesco is a great force in the grocery market. The major strengths of Tesco is: they have their focus on customers at all times, Like the MD would ask what do you need. They believe that when you look after your customers, everything else will look after itself. Yes other companies are as focused as Tescos, but size of the company is a great strength. Having more locations means selling more, cause most shoppers goes to the nearest shop to buy. The more locations for Tesco brings about selling more, and selling more brings about better buying terms ,and which brings about lower pricing and or higher profit margin. The lower prices then bring in higher sales volume. Tesco has made itself classless with price ranges formed to cater across the board.(Guardian 2010). In summary, Tescos focus on customers; their numerous stores scattered all over and their classless pricing is the major strength that brings about the market growth. They declare huge profits at all year. In spite of the recession, Tesco declared  £3.41 billion profit this April 2010 i.e. a 10% increment in profit as against 2009 financial report. However, the people have a high demand for Tesco products majorly because its close to them and because they sell cheaper and general items, you must need in one or two ways. They have a very high bargaining power over their suppliers and buyers. Their market growth rate is indeed very high. Market Share of Tesco The club card which rewards customers is a good contributor to Tescos success. There is a research group called dunhumby co owned by Tesco, they analyse the 16 million cards and study the buying habits of there shoppers and tailor offers to them. This factor contributes to their high market share. Tesco has existed for 91 years, and as such they multiply in size and complexity as the year goes bye. This has given rise to so many loyalists to the company. The various promo they arrange for their shoppers from time to time especially at this recession, helps build up Tescos market share. Tesco today has the highest market share in the grocery industry in the UK. 5.0 SWOT Analysis for Tesco (Explain a brief about swot) Strengths of Tesco The strengths are those things that propel the steady growth of Tesco. Usually, they are positive things .It could be by way of action of the company, process, or service. These include: the introduction of Tesco club card which not only makes them no the no. Of their dedicated customers, but helps in offer to their customers. Tesco have a very high reputation in the grocery market and as such that makes their market share so high. The technologies Tesco have are an added advantage to them and they try to improve on it everyday. The own label ranges e.g. Tesco finest; Their range of store format e.g. Tesco express convenience stores, Tesco metro stores which can be found on high street and in city centres, Tesco super stores and Tesco extra-Hypermarket. they have They have a very powerful supplier relations ion. The scattered locations they have is an added advantage, their strengths is very high and they beat their rivals in the industry, They have over 2300 locations outside the co untry and still expanding. This adds to their market share globally. They have got a good distribution chain; Tesco has a very strong brand. Their online services is an advantage as well, they offer high quality items to people. Most of the other grocers in the UK does not have their own research company, but Tesco does and has contributed towards Tesco growth, especially in the area of Tesco club card. Above all, it is pertinent to note that Tesco withstands every force that may likely affect their grocery business. Weaknesses This could be seen as things that could or makes Tesco not to meet their objectives. This weakness could also be seen as those elements that hampers the growth and development of Tesco. Though that there is no recognisable weakness of Tesco because of their core competency and team player spirit they posses. One recognisable weakness this report may suggest is that they need to improve on their market, they have not yet fully covered the whole of UK; they do not provide fresh fruits in Tesco, especially at Tesco Express. They have not gained full dominance in the world when it comes to retails. Opportunities These are those external things that could improve the Tesco more. Some of the opportunities of Tesco include: Tescos objective to open a Tesco cash and carry shop at India is an opportunity for them to explore. Tesco plans to open bank this year 2010,They hope to create more employment this year by recruiting about 9000 employees more. Some of the other grocer is not doing well at the moment, so that could be an opportunity for them to acquire them. Threats Threats of Tesco are those factors that are beyond the control of Tesco, and they are likely to jeopardize the company. Some of these threats include: The daisy nature of area of investment or diversification could pose a threat due to unforeseen events. Grocers could start to reduce price even to a break-even point. There could be Likely tendency of 2 or more mergers to form a more formidable player in the industry to compete with Tesco, unforeseen inflation could pose a threat to Tescos Strategy and the value rate of GBP is dropped gradually in recent times. 6.0 Vision Providing value, care and satisfaction to its customers and its people; through collaborative efforts. 6.1 Mission To maintain a strong core local and international business by creating value for customers to earn their lifetime loyalty. 6.2 Objectives of Tesco This report states that the objectives of Tesco are: providing customers with quality items that goes in commensuration with their money value; offering progressive returns on investment for their shareholders, improving on technology and investing on efficient stores and distribution depot for profit maximisation. Build a long term rapport with the suppliers so as to gain a lasting relationship based on price and quality level; help in protecting the environment; focusing on the community and catering for them, through the provision of customers needs based on steady soughting of their opinion on the aspect of quality, pricing, innovation, technology and other aspects whilst acting on them; awarding all its staff an equal opportunity , by giving them good training and proper management practices; contributing in the National Food Industry Policy, in the area of food hygiene, health safety and nutrition. 6.3 Measures Some of the things Tesco should adopt in order to achieve there objectives is to continue with low price and promos because people has not fully recovered from the recession, in addition, they should also continue to increase their locations because their are some places that Tesco needs to establish in. Doing this could go a great length to be building more and more their market share they should extend this to the Tesco international, as this would take them up a bit in the global ranking. They should adhere strictly to any laid down format towards achieving the companys objectives; these include Key performance Indicator. They should continue to maintain and protect the Environment locally and internationally. Never should they fail in constantly taking care of there customers by fulfilling their social responsibility. Tesco must continual with staff training and management practice across board and equally invest more on RD, for farther progress. 6.4 Strategic Intent Inasmuch as Tesco has attained a height in the grocery industry in the UK, they need to take it up to a commanding height of excellence by becoming the no. 1 in the globe. They need to establish anywhere favourable in Africa, after a careful research. In that case, this report suggests that Tesco should improve on the position they are at present, and climb to the next level as a world leader in food and non food market. 7.0 Strategic Development The summary of Tescos Objectives is to be an international retailer, maintain a strong core UK business, be as strong as in non food as in food, develop retailing services and put community at the heart of what they do. The Ansoff matrix will be a better tool to decide Tescos development strategy. Tesco need to improve, to be rated no 1 in the globe. Existing Products New Products Existing Market New Market Diagram 1: Ansoff Matrix Representation. 7.1 Market Penetration Tesco need to spread more of their products (its known already) spread more branches within UK so as to make business impossible for new entrant, and make business tougher for the existing ones, more customers will be using the product etc. Market development Tesco need to expand and as such this strategy will Tesco sell their existing products at new markets. This is most needed in the overseas where they are yet to be known. Product development This strategy is essential to adopt when Tesco wants to introduce any of their new products into an existing market like UK. Diversification It is a strategy that will enable Tesco market new products such as other non food items, in a new market. Tesco hope to establish a bank soonest in the UK, they could equally strategize on extending to other countries. They should adopt this strategy would help. 8.0 Strategic Implementation For market penetration strategy, it needs to be adapted to in order to boost the market share. They will achieve this by continually highly distinguished competitive price and more promotions for the customers, personal selling is encouraged and advertising. This will go a great length to dominate the market for Tesco. The management of Tesco needs to approve aggressive promotional campaign, with this will go vis-à  -vis a pricing strategy that will make other the market unattractive for other competitors. When they are doing this, they are restructuring a mature market for themselves. They also need to introduce a loyalty scheme. They should carry out a market development strategy to extend to those existing markets they have not been to with their already existing products. Just like some other countries in Asia. They should extend their existing products to such places. They need new competencies and those products should be modified so as to draw the attention of the existing market. Diversification could be a risky strategy. Tesco is about to start a Bank soon, which is expected to cash on opposition that exist amidst consumers toward UKs banks. (Guardian 2010),it is a good growth strategy for them, because this was what helped them, they started a non food items in 1997 which was led by Terry Leahy the chief Executive of Tesco (Tesco 2010) ands it immensely contributed to their profits. The Tesco non food raised 6.2% to  £13.1 billion with  £9 billion in the UK. They made  £4.1 billion in international. (Tesco corporate 2010). They should apply their usual process; use the competencies to carefully assess the risk involved and the gains in the diversification they would make. 9.0 Recommendations and Conclusion Inasmuch as Tesco is the leading grocer or retailer in the UK, they need to adopt the market penetration strategy of Ansoff matrix to dominate the market completely and broaden more and more their market share, thereby making the present notion that in every  £10 spent in grocery market in UK, Tesco account for  £3.The notion will change to every  £12 spent, Tesco accounts for  £6. It would be easier because they are not new in the market. Tesco need to use their competencies to extend and develop in foreign places, most especially Africa. They exist in almost other continents, but not Africa. Africa contributes either directly or indirectly so much towards the Economic growth in UK and America. (Lagos Chamber of commerce) Tesco should be continual in the study of customers so as to know the best strategy to adopt when there is another economic or socio-cultural situation. In conclusion, Tesco needs is a large diversified company and obviously they are doing better than others, but they still need to adhere to those measures and observe these suggested recommendations to be a world leader in retail industry. References/Bibliographies AICC (2010) Industry Analysis; The five forces [Online]. Available from: http://www.ces.purdue.edu/extmedia/ec/ec-722.pdf [Accessed: 26th April 2010] Economywatch (2010) Inflation; Economic inflation [Online]. Available from: http://www.economywatch.com/inflation/ [Accessed: 27th April 2010] Guardian, (2010) Tesco beats the recession to unveil record profits again [online].Available from: http://www.guardian.co.uk/business/2010/apr/25/tesco-record-profits-terry-leahy [Accessed: 25th April 2010] Porter M.E.(1980) Competitive Strategy; Technique for analysing industries and competitors. New York: First Free Press. Quick MBA (2007) Strategic Management [Online]. Available from: http://www.quickmba.com/strategy/porter.shtml [Accessed: 25th April 2010] Robson W. (2007). Strategic Management and Information Systems. 2ed. Harlow: Pearson Education Limited. Smith P. J. (2006). Strategic Planning Readings. Cape Town: Creda Communications Socyberty, (2007) Government intervention in the UK supermarket Industry [Online] Available from: http://socyberty.com/economics/government-intervention-in-the-uk-supermarket-industry/ [Accessed: 25th April 2010] Tesco PLC, (2009) Tesco Annual Reports and Financial Statements 2009 [Online] Available from: http://www.investis.com/tesco/pdf/repp2009.pdf [Accessed: 25th April 2010) Tesco corporate (2010) Tesco Plc Preliminary Results 2009/10 [Online] Available from: http://www.tescocorporate.com/plc/media/pr/pr2010/2010-04-20/ [Accessed: 27th April 2010) Tesco (2010) Media press releases 2010 [Online] Available from: http://www.tescoplc.com/plc/media/pr/pr2010/2010-04-20/ [Accessed: 27th April 2010]

Comparing Laurences West Side Story and Shakespeares Romeo and Juliet :: comparison compare contrast essays

Laurence's West Side Story and Shakespeare's Romeo and Juliet         Ã‚  Ã‚  Ã‚  Ã‚   Laurence's West Side story is an apparition of Shakespeare's Romeo and Juliet.   West Side Story and Romeo and Juliet differ in many ways.   Romeo and Juliet is set in Verona in about 1594.   West Side Story takes in New York City in 1957.   Tony is the modern character of Romeo and Maria is the modern character of Juliet.   In the two tragedies the major conflict is two opposing families, or gangs, do not agree of the relationship of their child.   This conflict was resolved in a very tragic manner, one of the two couples killed themselves the other couple just one got killed.   When the death of the persons happened is brought the two foes together.   West Side Story and Romeo and Juliet is indeed different in many ways.      Ã‚  Ã‚  Ã‚  Ã‚   Three incidents show Romeo and Juliet and West Side Story differs from one another.   The first thing shows the difference between Maria and Juliet, and Romeo and Tony.   When Juliet finds that her lover Romeo is dead Juliet kills herself.   Maria does not kill herself but instead she puts her sadness into treating the two gangs with a gun.   When Romeo finds Juliet supposedly dead he drinks poison to kill himself too.   Chino killed Tony because Chino was in love with Maria but so was Tony.   This is just one way that Romeo and Juliet differ from West Side Story.      Ã‚  Ã‚  Ã‚  Ã‚   Another way the two stories differ is the wealth of the two families, or gangs.   At the beginning of Romeo and Juliet, Shakespeare describes the Montague's and the Capulet's houses.   The size of the two houses shows how wealthy the families are.   In West Side Story the author only tells about the Sharks dwelling.   The Sharks live in an apartment which shows that the Sharks are not wealthy.   The Sharks and the Jets are very poor compared to the Capulets'' and the Montagues'.      Ã‚  Ã‚  Ã‚  Ã‚   Swords were used in Romeo and Juliet and guns were used in West Side Story.   The reason guns were used in West Side Story was to make the story more

vegetarianism Essay -- Healthy Lifestyle Essay

To most people vegetarianism means the refraining of meat, primarily red meat, from personal consumption. Although the traditional vegetarian abstinence of red meat has grown into a group of varied lifestyles, little is known about them. To some people vegetarians are considered to be a drop out of the hippy era, or are labelled as "weird" or "feral". Because of the misinterpretations surrounding vegetarianism in society I am going to outline the various diets which are recognized as vegetarianism. I hope by writing this I can change some attitudes and misunderstandings, of the motivations behind the vegetarian lifestyles. Plain vegetarianism; the first and most recognized is the general abstinence of red meat, some vegetarians see the consumption of white meats as acceptable, white meat includes fish, poultry and maybe even pork. They also consume dairy produce, eggs and any other form of animal produce used in their everyday lives. Vegetarians replace the red meat in their diets with vegetables, fruit and other vegetarian alternatives, these are usually processed foods made from either soya or gluten, there are also vegetarian burgers, which are made from formed vegetables. One of the variations of the red meat vegetarian, which closely follows the above description, is the ovo-lacto vegetarianism diet, which finds diary produce and eggs acceptable but no meat at all. Not even white meat, some ovo-lacto vegetarians consider fish to be acceptable, this is because categorically speaking fish is not considered meat, it is still flesh, and in my opinion constitutes as meat. Another recognized version of vegetarianism is the lacto vegetarian kind. These vegetarians consider meat; red and white, to be unacceptable, they also abstain from eggs. Dairy products are also a part of the lacto vegetarian lifestyle, the lack of animal eggs in the diet of these vegetarians is made up in the form of egg replaces and even meat alternatives like tofu can be used to simulate some egg dishes. Another path taken by vegetarians is the, pure vegetarian or vegan lifestyle. Which includes the abstinence of meat of all kinds, dairy produce, eggs, and all edible animal produce. To some vegans the diet exceeds the boundaries of food and takes on a full-scale animal product boycott. This comes in the abstinence of leather, fur, wool, silk and any other animal p... ...getables such as kale are as good or better then milk as calcium sources.  · Fat content - Other then skim varieties, dairy products are high in fat, as a percentage of total calories: Whole milk - 49% fat Cheddar cheese - 74% fat Butter - 100% fat  · Contaminants - Milk is frequently contaminated with antibiotics and excess vitamin D. Of 42 milk samples recently tested, only 12 percent were within the expected rand of vitamin D content. Of ten samples of infant formula, seven had more then twice the vitamin D content then reported on the label, and one had more than four times the label amount.  · Lactose - Many people of Asian and African heritage are unable to digest the milk sugar, lactose, which then causes diarrhea and gas. The Lactose sugar, when it is digested, releases galactose, a simple sugar which is linked to ovarian cancer and cataracts.  · Allergies - Milk is one of the most common causes of food allergy. Often the symptoms are subtle and may not be attributed to milk for some time.  · Colic - Milk proteins can cause colic, a digestive upset that bothers one in five infants. Milk-drinking mothers can also pass cow's milk proteins to their breast-feeding infants. vegetarianism Essay -- Healthy Lifestyle Essay To most people vegetarianism means the refraining of meat, primarily red meat, from personal consumption. Although the traditional vegetarian abstinence of red meat has grown into a group of varied lifestyles, little is known about them. To some people vegetarians are considered to be a drop out of the hippy era, or are labelled as "weird" or "feral". Because of the misinterpretations surrounding vegetarianism in society I am going to outline the various diets which are recognized as vegetarianism. I hope by writing this I can change some attitudes and misunderstandings, of the motivations behind the vegetarian lifestyles. Plain vegetarianism; the first and most recognized is the general abstinence of red meat, some vegetarians see the consumption of white meats as acceptable, white meat includes fish, poultry and maybe even pork. They also consume dairy produce, eggs and any other form of animal produce used in their everyday lives. Vegetarians replace the red meat in their diets with vegetables, fruit and other vegetarian alternatives, these are usually processed foods made from either soya or gluten, there are also vegetarian burgers, which are made from formed vegetables. One of the variations of the red meat vegetarian, which closely follows the above description, is the ovo-lacto vegetarianism diet, which finds diary produce and eggs acceptable but no meat at all. Not even white meat, some ovo-lacto vegetarians consider fish to be acceptable, this is because categorically speaking fish is not considered meat, it is still flesh, and in my opinion constitutes as meat. Another recognized version of vegetarianism is the lacto vegetarian kind. These vegetarians consider meat; red and white, to be unacceptable, they also abstain from eggs. Dairy products are also a part of the lacto vegetarian lifestyle, the lack of animal eggs in the diet of these vegetarians is made up in the form of egg replaces and even meat alternatives like tofu can be used to simulate some egg dishes. Another path taken by vegetarians is the, pure vegetarian or vegan lifestyle. Which includes the abstinence of meat of all kinds, dairy produce, eggs, and all edible animal produce. To some vegans the diet exceeds the boundaries of food and takes on a full-scale animal product boycott. This comes in the abstinence of leather, fur, wool, silk and any other animal p... ...getables such as kale are as good or better then milk as calcium sources.  · Fat content - Other then skim varieties, dairy products are high in fat, as a percentage of total calories: Whole milk - 49% fat Cheddar cheese - 74% fat Butter - 100% fat  · Contaminants - Milk is frequently contaminated with antibiotics and excess vitamin D. Of 42 milk samples recently tested, only 12 percent were within the expected rand of vitamin D content. Of ten samples of infant formula, seven had more then twice the vitamin D content then reported on the label, and one had more than four times the label amount.  · Lactose - Many people of Asian and African heritage are unable to digest the milk sugar, lactose, which then causes diarrhea and gas. The Lactose sugar, when it is digested, releases galactose, a simple sugar which is linked to ovarian cancer and cataracts.  · Allergies - Milk is one of the most common causes of food allergy. Often the symptoms are subtle and may not be attributed to milk for some time.  · Colic - Milk proteins can cause colic, a digestive upset that bothers one in five infants. Milk-drinking mothers can also pass cow's milk proteins to their breast-feeding infants.

Financial Outlook on Dr. Reddy’s Laboratories

International Finance Project On â€Å"Financial outlook on Dr. Reddy’s Laboratories Ltd. † Submitted to: Prof. S. K. Gupta Submitted by: Date: 31 Dec. 2011 SOURAV KUMAR 2K10IB30 PGDM IB 2010-2012 ASIA PACIFIC INSTITUTE OF MANAGEMENT 3 & 4, Institutional Area, Jasola, New Delhi 110025 INTRODUCTION Established in 1984, Dr. Reddy's Laboratories Ltd. (NYSE: RDY) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses – Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars, differentiated formulations and News Chemical Entities (NCEs). PURPOSE & VALUES: Providing Affordable Medicines Our Global Generics business helps reduce drug costs for individuals and governments by bringing generic drugs to market as early as possible, and making them available to as many patients as possible. We market both generic small-molecule drugs and generic biopharmaceuticals. In markets with guidelines for approval, our Biologics business offers more affordable and equally effective generic biopharmaceuticals or biosimilars. We supply pharmaceutical ingredients to other generic companies through the API arm of our PSAI business, which contributes to our goal of providing affordable edicine. We will continue to promote affordability in significant ways and work to expand our product offering of generics, focusing on increasing access to products with significant barriers to entry. We will continue to look for new opportunities to take generics to more patients, in collaboration with other companies. Developing Innovative Medicines Despite the great advances of medical science, there are still many unmet medical needs. Our Proprietary Products businesses address some of these unmet medical needs, by developing and bringing to market new drugs. Through innovation in science and technology, combined with a deep understanding of underlying disease pathways, we develop and commercialise new formulations of approved products. We also develop new chemical entities with improved and well-characterised safety and efficacy profiles. We focus our research on the therapeutic areas of pain, anti-bacterials and metabolic disorders. Our Custom Pharmaceutical Services arm of our PSAI business helps innovator companies get their proprietary medicines to patients faster, by providing a range of technology platforms and services. ABOUT THE BUSINESS: The healthcare needs of people worldwide cannot be met by one company alone. Collectively however we can bring new drugs to the market in a fast and efficient manner and provide the building blocks of affordable medicines. Through our PSAI business, which comprises the Active Pharmaceutical Ingredients (API) and Custom Pharmaceutical Services (CPS) businesses, we offer IP advantaged, speedy product development and cost-effective manufacturing services to our customers – generic companies and innovators. This allows us to help make good medicines available to more people around the world. The core strengths of our PSAI business are the state-of-the-art infrastructure, resources and skills we are able to offer to our customers: †¢Large and diverse product portfolio †¢Eight FDA-inspected plants and three technology centers †¢World class chemistry expertise †¢Robust, large-scale manufacturing capabilities †¢Intellectual Property (IP) driven product development for freedom to operate †¢Total, seamless supply chain management PARTNERSHIP PHILOSPHY: At the core of each successful partnership is a great relationship based on trust and mutual respect. As we work towards fulfilling our core purpose we share your aspirations. We recognize and embrace the fact that our partners are a core component of this strategy. We understand that partnerships are successful when benefits accrue to both parties. They are built on a shared vision with well-defined and agreed-upon goals. We also know that that the partners’ thinking and interests may not always be identical, but that we share the same goal—a successful product. Our shared partnership successes are at the very heart of our business. From our first meeting through product launch and beyond, we stand behind our belief in true partnership thereby combining our strengths and sharing our successes. Dr. Reddy's firmly believes that the right alliances can contribute significantly to the success of our partners as well as to our own strategy and sustainable growth. â€Å"At Dr. Reddy’s we aim to foster a culture of building fair, effective, and mutually beneficial—winning—collaborations. The importance that we place on building winning collaborations is evidenced partly by the early and substantial involvement of senior management. In this way, we achieve quick decision-making and the allocation of necessary resources to achieve success. † G V Prasad Vice Chairman and CEO Transparent and Simple process: Clarity of thought, Speed of execution, Flexibility, creativity, and transparency are critical components of our negotiation and transaction process. As no two deals are the same, we work with potential partners to structure deals through customized approaches that allow both partners to leverage unique capabilities and assets in order to achieve common goals. A simple and streamlined process to progress our partnering discussions and a flat organizational structure facilitates rapid decision making from initial screening to execution. As a company that evaluates 100+ business development opportunities in any given year (many of which come to closure), we value the time and resources our potential partners commit to explore and complete any potential partnership. Dr. Reddy’s emphasizes a transparent and collaborative negotiation process and prompt decision making. We bring a reputation for acting swiftly and being flexible. We will work with you to reach an agreement with which you will be comfortable and that will head us in the right direction toward shared success. Sustained relationship based on trust and mutual respect: Our robust alliance management principles and practices allow successful execution of joint initiatives. Dr. Reddy’s is committed to ensuring that our partnerships succeed and flourish. Quarterly Results: Quarterly Results of Dr Reddys Laboratories——————- in Rs. Cr. ——————- Sep '11Jun '11Mar '11Dec '10Sep '10 Sales Turnover1,646. 981,696. 961,329. 161,389. 761,296. 88 Other Income13. 0555. 5429. 1137. 2152. 35 Total Income1,660. 031,752. 501,358. 271,426. 971,349. 23 Total Expenses1,390. 181,085. 201,113. 741,046. 631,022. 98 Operating Profit256. 80611. 76215. 42343. 13273. 0 Profit On Sale Of Assets———- Profit On Sale Of Investments———- Gain/Loss On Foreign Exchange———- VRS Adjustment———- Other Extraordinary Income/Expenses———- Total Extraordinary Income/Expenses———- Ta x On Extraordinary Items———- Net Extra Ordinary Income/Expenses———- Gross Profit269. 85667. 30244. 53380. 34326. 25 Interest15. 7815. 244. 250. 540. 13 PBDT254. 07652. 06257. 78379. 80326. 12 Depreciation73. 4068. 9365. 5063. 8961. 35 Depreciation On Revaluation Of Assets———- PBT180. 67583. 13192. 28315. 91264. 77 Tax42. 17129. 0826. 4153. 1444. 57 Net Profit138. 50454. 05165. 87262. 77220. 20 Prior Years Income/Expenses———- Depreciation for Previous Years Written Back/ Provided———- Dividend———- Dividend Tax———- Dividend (%)———- Earnings Per Share8. 1726. 799. 8015. 5313. 01 Book Value———- Equity84. 7684. 7484. 6384. 6184. 60 Reserves———- Face Value5. 005. 005. 005. 005. 00 ___________________________________________ Balance Sheet of the company (annually): ——————- In Rs. Cr. —————————— DescriptionMar-11Mar-10Mar-09Mar-08 SOURCES OF FUNDS: Share Capital84. 684. 484. 284. Share Warrants & Outstanding39. 333. 935. 532. 5 Total Reserves5896. 35796. 35139. 44695. 2 Shareholder's Funds6020. 25914. 65259. 14811. 8 Secured Loans0. 70. 82. 63. 4 Unsecured Loans1444. 1562. 4637. 745 8. 9 Total Debts1444. 8563. 2640. 3462. 3 Total Liabilities74656477. 85899. 45274. 1 APPLICATION OF FUNDS : Gross Block30252425. 72157. 31750. 2 Less: Accumulated Depreciation13341110. 1946. 5762. 8 Less: Impairment of Assets Net Block16911315. 61210. 8987. 4 Lease Adjustment A/c Capital Work in Progress570. 4745. 4411. 2246. 5 Pre-operative Expenses pending Assets in transit Investments24622555. 1703. 81930. 6 Current Assets, Loans & Advances Inventories1063. 2897. 4735. 1640. 9 Sundry Debtors1770. 51060. 51419. 7897. 7 Cash and Bank66. 2368384. 4536. 7 Other Current Assets1. 80. 62. 8 Loans and Advances2606. 42048. 718401250. 6 Total Current Assets5506. 34376. 44379. 83328. 7 Less: Current Liabilities and Provisions Current Liabilities1440. 71447. 51050. 2680. 9 Provisions1223. 2992. 2665. 6451. 3 Total Current Liabilities2663. 92439. 71715. 81132. 2 Net Current Assets2842. 41936. 726642196. 5 Miscellaneous Expenses not written off Deferred Tax Assets / Liabilities-100. 8-75-90. 4 -86. 9 Total Assets74656477. 85899. 45274. 1 Contingent Liabilities2488. 22412. 21977. 93325. 8 Book Value353. 481087348. 382701310. 190024284. 143876 Adjusted Book Value353. 481087348. 382701310. 19284. 1439 Profit & Loss Statement of the company (annually) ——————- in Rs. Cr. ————————————— DescriptionMar-11Mar-10Mar-09Mar-08 No of Months12121212 INCOME : Gross Sales5284. 74543. 84239. 83449. 7 Less: Inter divisional transfers Less: Sales Returns Less: Excise Duty97. 37480. 984. 5 Net Sales5187. 44469. 84158. 93365. 2 EXPENDITURE : Increase/Decrease in Stock-79-117. 3-64. 1-93. Raw Material Consumed1396. 413461177. 61146. 1 Power & Fuel Cost144. 6104. 19077. 1 Employee Cost701. 2510413. 3368. 6 Other Manufacturing Expenses1053. 9793. 3894698. 2 General and Administration Expenses288. 7195. 6228193. 9 Selling and Distribution Expenses477443. 8448. 7375. 4 Misce llaneous Expenses113. 991. 6121. 930 Less: Expenses Capitalised Total Expenditure4096. 73367. 13309. 42795. 4 Operating Profit (Excl OI)1090. 71102. 7849. 5569. 8 Other Income219220. 5101. 1191. 1 Operating Profit1309. 71323. 2950. 6760. 9 Interest9. 91627. 414. 7 PBDT1299. 81307. 2923. 2746. 2 Depreciation247. 9222. 4193. 162 Profit Before Taxation & Exceptional Items1051. 91084. 8729. 5584. 2 Exceptional Income / Expenses Profit Before Tax1051. 91084. 8729. 5584. 2 Provision for Tax158. 5238. 7168. 6108. 9 Profit After Tax893. 4846. 1560. 9475. 3 Extra items Adjustments to PAT597. 2-24. 8-1. 5 Profit Balance B/F2554. 12039. 11657. 51305. 1 Appropriations4044. 72860. 42218. 41778. 9 Equity Dividend %22522512575 Earnings Per Share52. 801418450. 124407633. 307628. 258 Adjusted EPS52. 801418450. 124407633. 307628. 258 Forex and External commercial borrowings: ——————- in Rs. Cr. ————————â €”———— DescriptionMar-11Mar-10Mar-09Mar-08 EXPORTS Total Inflow In Foreign Currency3747. 73161. 43123. 32366. 8362 Exports – FOB Value3671. 83013. 82892. 52259. 9061 Revenue in Forex75. 9147. 6230. 8106. 9301 Frieght & Insurance Technology transfer fees Service Fees31111. 1197. 959. 2134 Commision Earned2. 4 Dividend received Interest Earnings33. 635. 13236. 8753 Other Exports8. 91. 40. 910. 8414 Capital Inflow – Other Deemed Exports IMPORTS Total Outflow In Foreign Currency1321. 31021. 41180. 91071. 0232 Imports – CIF Value533. 7486. 4553. 8658. 4784 Raw Materials533. 7486. 4553. 8658. 4784 Traded Goods Stores & spares Other Imports Total Capital Outflow277. 3110. 7135. 577. 1814 Capital Goods277. 3110. 7135. 577. 1814 Other Capital Expenditures Repayments of Loans Investment In foreign Currency Expenditure in Foreign Currency510. 3424. 3491. 6335. 3634 Travelling Expenses5. 16109. 385 Interest Expenditure7. 5 Legal Expenses113. 166. 652. 355. 1145 Royalty Technical Fees Commision paid Others384. 6351. 7429. 3270. 8639 Dividend Paid Deemed Imports Raw Materials consumed Material Imported in Amt456. 6334. 2357231. 2115 Material Imported in %43303926. 37 Material Indigenous in Amt609. 8766. 3564. 2645. 144 Material Indigenous in %57706173. 63 Stores and spares consumed Spare Imported in Amt52. 433. 230. 121. 2313 Spares Imported in %1513811 Spare Indigenous in Amt300. 7220. 3326. 3180. 0892 Spares Indigenous in %85879289 Dr Reddy's Laboratories in News Dr Reddy's Laboratories: Higher capacity, New products to pump up growth Kiran Kabtta Somvanshi, ET Bureau Dec 26, 2011, 05. 20am IST Tags: †¢Sun Pharma| †¢Russia| †¢Germany| †¢generics Dr Reddy's Laboratories, the second-largest pharma company (by sales) in India, is at an inflexion point. Its robust performance in the US and Russia is driving its growth. The second half of the fiscal is likely to be better for the company than the first one –characterised by more product launches and increase in market share. It's probably the right time for investors to consider this stock. BUSINESS The company is engaged in generics, bulk drugs & custom services and proprietary products. The genericsbusiness contributes over 70% to its total revenues, which stood at $1. 7 billion in FY11. DRL has focussed on four key regions — North America, India, Russia/CIS and Europe — with an objective to achieve critical mass in the base business. North America is the company's largest and strongest market, contributing onethird of the company's revenues. New product launches, limited competition products and improved market share has helped the company post a strong performance in the region. DRL's German business remains its sore point, pulling down the growth rates for the European region. The pricing pressure brought about by the tender-based business structure has adversely affected its profitability. The Indian business has been a laggard since the last several quarters, but the sequential improvement in its performance in the September quarter is encouraging. Its biosimilars portfolio has done very well and has logged a growth of 22% y-o-y, hinting at a better period in the coming months. The Russian business, though not a large contributor, has proved to be yet another growth driver for the company. The OTC business, in particular, is doing well in the region. GROWTH DRIVERS DRL has targeted revenues of $3 billion and a RoCE of 25% in FY13. The company has a strong pipeline with 76 pending ANDAs (17 tentative approvals). It has 40 Para IV filings of which 11 have first to file opportunities. The company is focussing on scaling up manufacturing and having a higher mix of US generics in total global generics. In Germany, the company has undertaken cost control measures, and has commenced supplies to AOK tenders and launched new products outside the scope of tenders. Its effect would be visible from the current quarter. DRL has a tie-up with GSK to develop and market select products across emerging markets outside India. FINANCIALS While its earnings have been erratic over the years, the company's revenues have grown at a CAGR of around 21% over the last decade. DRL has restructured operations at its German and Mexican units. It has capped risky and expensive R by pulling out research in therapies like diabetes and cardiovascular. Instead, it is now channelising its R efforts towards development of limited competition products, biosimilars and new chemical entities in areas like pain management, anti-infectives and dermatology. CONCERNS Forging growth in its Indian business and profitability in its European operations is a major concern for the company. Its future growth depends on the success of its efforts in these areas. The company has raised `1,077-crore debt in the current quarter to meet working capital requirements and also to refinance old loans. This brings its total debt to over `4,200 crore. VALUATIONS The company's stock is trading at 23 times its consolidated annual earnings. These valuations are lower than its better-performing peers like Sun Pharma and Cipla. Pharma cos with huge FCCBs may not get hit as their export earnings remaining high Sanjay Pingle, Mumbai Monday, December 19, 2011, 08:00 Hrs [IST] Steady depreciation of Rupee against US Dollar and Euro may not have any major impact on Indian pharmaceutical industry despite many pharma companies have huge exposure to foreign currency loans and bonds. To a great extend, such adverse rates will be offset by the sizable export earnings of Indian pharma companies. Continuous depreciation of Indian Rupee against US Dollar and Euro is a great concern for Indian manufacturers having Foreign Currency Loans (FCLs) and Foreign Currency Convertible Bonds (FCCBs). But the exports of these companies are likely to shoot up in 2011-12 with depreciation of rupee in terms of foreign currencies. Indian pharma companies have recorded export earnings of more than 50 per cent of their revenues to US and Europe during 2010-11 and with depreciation of Rupee export earnings are likely to go up significantly. This will reduce the adverse effect on bottom line likely with the current unfavorable foreign exchange rates. Uncertainty in Euro region and recessionary conditions worldwide is making Dollar more firm against several currencies. At present, the exchange rate of Indian Rupee against dollar is moving near to Rs. 55 and that of Euro is moving over Rs. 71 as against Rs. 45. 87 per Dollar and Rs. 61. 13 per Euro year ago. The Dollar appreciated nearly by 20 per cent and Euro by almost 17 per cent within one year making FCL and Foreign Currency Convertible Bonds (FCCBs) payments costlier for Indian companies. The pharma industry has already incurred huge foreign currency loss during the first half of 2011-12 and these are likely to increase in the remaining part of the FY'12 with adverse exchange fluctuations. Though the Indian pharmaceutical companies have created strong networth position in the past, the volatile and adverse change in foreign exchange rates may put pressure on bottom line. The borrowings of Pharmabiz sample of leading 35 companies shows that the total borrowings, including secured and non-secured loan went up by 18. 3 per cent to Rs. 37,709 crore during 2010-11 from Rs. 1,899 crore in the previous year. The secured loans, including foreign currency loans and FCCBs, of 35 companies increased by 19. 8 per cent to Rs. 21,899 crore from Rs. 18,278 crore. As against these borrowings, the net worth, equity capital plus reserves & surplus, of these companies stood at Rs. 68,201 crore as compared toRs. 48,811 crore in the previous year, representing a strong growth of 39. 7 per cent in 2010-11. Out of 35 companies, 23 companies availed FCL or issued FCCBs and the aggregate amount worked out to Rs. 9,560 crore in 2010-11 as compared to Rs. 10,765 crore. Thus, FCL and FCCBs comprised of 25 per cent in 2010-11 of aggregate borrowings as compared to 34 per cent in the last year. The reduction is mainly due to redemption of FCCBs by few companies and repayment of costly FCLs. The aggregate amount of FCCBs issued by these companies reduced by 12 per cent to Rs. 5,382 crore from Rs. 6,118 crore and foreign currency loans by 10. 1 per cent to Rs. 4,178 crore from Rs. 4,647 crore. Ranbaxy Laboratories has outstanding FCCBs aggregating to US$ 440 million as at the end of December 2010. The company has shown Rs. 1,967 crore as unsecured loan for FCCBs as compared to Rs. ,048 crore in the previous year. Orchid Chemicals and Pharmaceuticals has outstanding FCCBs of Rs. 523. 58 crore as against Rs. 607. 74 crore in the 2009-10. Jubilant Lifesciences has reduced its FCCBs amount to Rs. 633. 70 crore from Rs. 861 crore in the previous year. Further, Strides Arcolab has reduced its FCCBs loan to Rs. 457. 28 crore from Rs. 634. 15 crore and Aurobind o Pharma toRs. 620. 76 crore from Rs. 767. 71 crore. Wockhardt's FCCB liabilities increased slightly to Rs. 458. 82 crore from Rs. 446. 40 crore and that of Plethico Pharma's to Rs. 425. 12 crore from Rs. 411. 91 crore. The foreign currency loans (FCLs) of Jubilant Lifesciences went up to Rs. 1755. 71 crore from Rs. 1580. 48 crore and that of Cadila's to Rs. 737. 70 crore from Rs. 722. 80 crore. Biocon has successfully reduced its FCLs to Rs. 189. 94 crore from Rs. 220. 72 crore. Dr Reddy's Laboratories has repaid its FCLs ofRs. 889. 90 crore during 2010-11 through three new short-term borrowings. However, FCL of Lupin went up sharply to Rs 306. 54 crore from Rs. 181. 99 crore in the previous year. Further, FCL of Orchid Chemical went up to Rs. 325. 22 crore from Rs. 250. 02 crore and that of Panacea Biotec to Rs. 359. 4 crore from Rs. 293. 74 crore. Ipca Laboratories FCLs also jumped to Rs. 183. 15 crore from Rs. 125. 52 crore. The sample of Pharmabiz 35 companies have managed to reduce their liabilities in respect of FCCBs and FCLs during 2010-11 and likely to reduce risk of depreciation of Rupee against Dollar and Euro. Further rise in interest rates by RBI will also put additional burden on the sector in 2011-12. However, higher exports may assist to reduce adverse impact on working. Dr. Reddy’s Q2 FY12 Financial Results : Q2 FY12 Revenues at ? 22. 7 billion ($462 million), YoY growth of 21%; Q2 FY12 Adjusted* EBITDA at ? 5. billion ($104 million), YoY growth of 20%; Q2 FY12 Adjusted** PAT at ? 3. 1 billion ($63 million), YoY growth of 8% Hyderabad, India, October 25, 2011: Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) today announced its unaudited consolidated financial results for the quarter ended September 30, 2011 under International Financial Reporting Standards (IFRS). Key Highlights †¢Consolidated revenues are at ? 22. 7 billion ($462 million) in Q2 FY12 versus ? 18. 7 billion ($381 million) in Q2 FY11, year-on-year growth of 21%. Consolidated revenues for H1 FY12 is at ? 42. 5 billion ($866 million). oRevenues from Global Generics for Q2 FY12 are at ? 6. 1 billion ($329 million). Year-on-year growth of 18% mainly driven by North America and Russia. oRevenues from PSAI are at ? 5. 9 billion ($121 million) in Q2 FY12, growth of 28% over previous year. †¢Adjusted* EBITDA of ? 5. 1 billion ($104 million) in Q2 FY12, is at 23% of revenues recording year-on-year growth of 20%. Consolidated adjusted EBITDA for H1 FY12 is at ? 9. 4 billion ($193 million). †¢Adjusted** Profit after Tax for Q2 FY12 is at ? 3. 1 billion ($63 million), is at 14% of revenues with year-on-year growth of 8%. Consolidated adjusted PAT for H1 FY12 is at ? 5. 6 billion ($115 million). During the quarter, the company launched 28 new generic products, filed 17 new product registrations and filed 11 DMFs globally. †¢Dr. Reddy’s today announced the final approval of its olanzapine 20 mg tablets, the generic version of Eli Lilly’s Zyprexa ®from the USFDA. *Note: Adjustments include: benefit from a part reversal of provision booked in Q1 for Voluntary Retirement Scheme (VRS) floated by the company. **Note: Adjustments include: a) intere st on bonus debentures and b) benefit from a part reversal of provision booked in Q1 on account of Voluntary Retirement Scheme (VRS) floated by the company. All figures in millions, except EPS All dollar figures based on convenience translation rate of 1USD = ? 49. 05 Dr. Reddy's Laboratories Limited and Subsidiaries Unaudited Consolidated Income Statement ParticularsQ2 FY12Q2 FY11Growth % ($)(? )%($)(? )(%) Revenue46222,67910038118,70410021 Cost of revenues21410,473461788,7184720 Gross profit24912,206542049,9865322 Operating Expenses Selling, general & administrative expenses1477,216321165,7093126 Research and development expenses301,4596261,270715 Other operating (income) / expense(4)(215)(1)(4)(218)(1)(2) Results from operating activities763,74517663,2251716 Net finance (income) / expense1500135042 Share of (profit) / loss of equity accounted investees(0)(13)(0)(0)(3)(0)- Profit / (loss) before income tax763,70916653,1941716 Income tax (benefit) / expense1363137327293 Profit / (loss) for the period633,07814582,867157 Diluted EPS0. 418. 1 0. 316. 9 Profit Reconciliation: Adjusted EBITDA ReconciliationQ2 FY12Q2 FY11 ($)(? )($)(? ) PBT763,709653,194 Interest522506 Depreciation1887915731 Amortization83896317 EBITDA1065,203874,248 Adjustments: Part reversal of provision booked in Q1 for Voluntary Retirement Scheme(2)(94) Adjusted EBITDA1045,109874,248 Adjusted PAT ReconciliationQ2 FY12Q2 FY11 ($)(? ($)(? ) PAT633,078582,867 Adjustments: Interest on Bonus Debentures2118 Part reversal of provision booked in Q1 for Voluntary Retirement Scheme(2)(94) Tax normalizing adjustment(0)(4) Adjusted PAT633,099582,867 Segmental Analysis Global Generics Revenues from Global Generics segment are at ? 16. 1 billion ($329 million) in Q2 FY12 registering growth of 18% over previous year. †¢Reven ues from North America at ? 6. 3 billion in Q2 FY12 versus ? 4. 4 billion in Q2 FY11. Growth in USD terms of 45% was led by new product launches in the last twelve months and market share improvement in key products. 5 new products launched during the quarter, including limited competition products such as fondaparinux and fexofenadine pseudoephedrine D24 OTC. o24 products of our prescription portfolio feature among the Top 3 rank in market share (Source: IMS Sales Volumes July 2011). oDuring the quarter, 4 ANDAs were filed. The cumulative ANDA filings as of 30th September, 2011 are 177. A total of 76 ANDAs are pending for approval with the USFDA of which 40 are Para IVs and 11 are FTFs. †¢Revenues in Russia & Other CIS markets at ? 3. 4 billion in Q2 FY12 versus ? 2. 8 billion in Q2 FY11, year-on-year growth of 23%. Revenues in Russia at ? 2. 9 billion in Q2 FY12 versus ? 2. 3 billion in Q2 FY11, year-on-year growth in USD terms of 30%, largely driven by volume growth in key b rands. ?OTC portfolio growth of 33% over previous year; OTC sales at 25% of overall Russia sales. ?Dr. Reddy’s year-on-year secondary prescription sales growth at 20% versus industry’s growth of 10%. (Source: Pharmexpert August 2011). Dr. Reddy’s is ranked 12th in market share. oRevenues in Other CIS markets remained flat at ? 477 million in Q2 FY12. †¢Revenues in India increased by 9% to ? 3. 5 billion in Q2 FY12 versus ? . 2 billion in Q2 FY11. o3 new products launched during the quarter. oBiosimilar portfolio growth of 22% over previous year ; represents 6% to sales. †¢Revenues from Europe at ? 2. 1 billion in Q2 FY12, declined by 10% over previous year. oRevenues from Germany declined by 27% to ? 1. 2 billion in Q2 FY12 due to continuing impact of tenders. oRevenues from Rest of Europe grew by 26% to ? 933 million in Q2 FY12 driven by new launches in UK and growth in out-licensing business. Pharmaceutical Services and Active Ingredients (PSAI) â₠¬ ¢Revenues from PSAI are at ? 5. billion in Q2 FY 12 versus ? 4. 6 billion in Q2 FY11, year-on-year increase of 28%. oGrowth in Active Ingredients business led by new product launches in Europe. oPharmaceutical Services business grew on account of improved customer order book status. oDuring the quarter, 11 DMFs were filed globally, with 2 in US, 2 in Europe, 1 in Canada and 6 in rest of the markets. The cumulative DMF filings as of 30th September 2011 are 506. Income Statement Highlights: †¢Gross profit at ? 12. 2 billion ($249 million) in Q2 FY12, margin of 54% to revenues, marginal increase over previous year. Selling, General & Administration (SG&A) expenses including amortization at ? 7. 2 billion ($147 million) increased by 26% over Q2 FY11. This increase is on account of a) higher freight costs both on account of increase in sales volumes as well as rate increases, b) inflation and year-on-year increments linked increase in manpower costs across businesses, c) increment al costs at Bristol and Shreveport manufacturing facilities in the US and d) the increase in the OTC-related selling and marketing costs in Russia and other CIS markets as compared to previous year. R&D expenses at ? 1. 5 billion ($30 million) in Q2 FY12, increase of 15% over Q2 FY11. †¢Net Finance costs are at ? 50 million ($1 million) in Q2 FY 12 versus ? 35 million ($0. 7 million) in Q2 FY11 The change is on account of : oNet forex gain of ? 151 million ($3 million) versus net forex loss of ? 49 million ($1 million) in Q2 FY11. oNet interest expense of ? 225 million ($5 million) in Q2 FY12 versus ? 5 million ($0. 1 million) in Q2 FY11. oProfit on sale of investments of ? 25 million ($0. 5 million) in Q2 FY12 versus ? 19 million ($0. 4 million) in Q2 FY11. Adjusted EBITDA of ? 5. 1 billion ($104 million) in Q2 FY12, is at 23% of revenues with year-on-year growth of 20%. †¢Adjusted Profit after Tax for Q2 FY12 is at ? 3. 1 billion ($63 million), is at 14% of revenues with year-on-year growth of 8%. †¢Adjusted EPS for Q2 FY 12 is at ? 18. 2 ($0. 4) versus ? 16. 9 ($0. 3) in Q2 FY11. †¢Capital expenditure for H1 FY12 is at ? 3. 6 billion ($73 million). Appendix 1: Q2 FY12 Key Balance Sheet Items (In millions) ParticularsAs on 30th Sep 11As on 30th Jun 11 $)(? )($)(? ) Cash and cash equivalents1557,5961115,468 Trade receivables41920,56834917,136 Inventories37918,59235517,401 Property, plant and equipment64131,45062230,524 Goodwill and other intangible assets30815,11530414,921 Loans and borrowings (current & non-current)63831,30348823,940 Trade payables1828,9401728,433 Equity98048,08199748,902 Appendix 2: Q2 FY12 Revenue Mix by Segment (In millions) Q2 FY12Q2 FY 11Growth % ($)(? )as a %($)(? )as a % Global Generics32916,1367127913,6677318 North America 6,28739 4,4163242 Europe 2,11713 2,36617(10) India 3,45921 3,160239 Russia & Other CIS 3,38021 2,7512023 RoW 8936 9747(8) PSAI1215,93326944,6172528 North America 1,06818 8141831 Europe 2,30339 1,5513448 India 75213 6531415 RoW 1,81031 1,5993513 Others1261039420245 Total46222,67810038118,70410021 Appendix 3: Q2 FY12 Revenue Mix by Geography (In millions) Q2 FY12Q2FY 11Growth % ($)(? )as a %($)(? )as a % North America1597,777341115,4642942 Europe924,53620844,1022211 India864,21019783,8132010 Russia & Other CIS693,38015562,7511523 Others572,77512522,573148 Total46222,67810018,70418,10021 Appendix 4: H1 FY12 Consolidated Income Statement All figures in millions, except EPS All dollar figures based on convenience translation rate of 1USD = ? 49. 05 ParticularsH1 FY12H1 FY11Growth % ($)(? )%($)(? )(%) Revenue86642,46210072435,53510019 Cost of revenues40219,7014633916,6354718 Gross profit46422,7615438518,9005320 Operating Expenses Selling, general & administrative expenses28513,9723322811,1913125 Research and development expenses542,6566462,263617 Other operating (income) / expense(8)(401)(1)(8)(404)(1)(1) Results from operating activities1336,533151195,8501612 Net finance (income) / expense296042121(55) Share of (profit) / loss of equity accounted investees(0)(17)(0)(0)(8)(0)113 Profit / (loss) before income tax1326,455151155,6471614 Income tax (benefit) / expense15751214684210 Profit / (loss) for the period1165,704131014,9631415 Diluted EPS0. 733. 6 0. 629. 2 Appendix 5: H1 FY12 Profit Reconciliation (In millions) Adjusted EBITDA ReconciliationH1 FY12H1 FY11 ($)(? )($)(? ) PBT1326,4551155,647 Interest9446(0)(3) Depreciation351,708291,416 Amortization1679412605 Reported EBITDA1929,4041567,665 Adjustments: One-time charge of Voluntary Retirement Scheme142 Adjusted EBITDA1939,4451567,665 Adjusted PAT ReconciliationH1 FY12H1 FY11 ($)(? )($)(? ) Reported PAT1165,7041014,963 Adjustments: Interest on Bonus Debentures5236 One-time charge of Voluntary Retirement Scheme142 Tax normalizing adjustment(7)(364) Adjusted PAT1155,6181014,963